Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients

High-grade serous ovarian carcinoma (HGSOC) usually spreads directly into the peritoneal cavity following a transcoelomic dissemination route, although distant hematogenous metastasis exist and have been reported. However, no tumor markers can currently predict the risk of distant metastases in HGSO...

Full description

Bibliographic Details
Main Authors: Chiara Romani, Valentina Zizioli, Marco Silvestri, Laura Ardighieri, Mattia Bugatti, Michela Corsini, Paola Todeschini, Sergio Marchini, Maurizio D'Incalci, Laura Zanotti, Antonella Ravaggi, Fabio Facchetti, Angela Gambino, Franco Odicino, Enrico Sartori, Alessandro Davide Santin, Stefania Mitola, Eliana Bignotti, Stefano Calza
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01287/full
_version_ 1831726003023511552
author Chiara Romani
Chiara Romani
Valentina Zizioli
Marco Silvestri
Marco Silvestri
Laura Ardighieri
Mattia Bugatti
Michela Corsini
Paola Todeschini
Sergio Marchini
Maurizio D'Incalci
Laura Zanotti
Antonella Ravaggi
Antonella Ravaggi
Antonella Ravaggi
Fabio Facchetti
Angela Gambino
Angela Gambino
Franco Odicino
Franco Odicino
Enrico Sartori
Enrico Sartori
Alessandro Davide Santin
Stefania Mitola
Eliana Bignotti
Eliana Bignotti
Stefano Calza
Stefano Calza
author_facet Chiara Romani
Chiara Romani
Valentina Zizioli
Marco Silvestri
Marco Silvestri
Laura Ardighieri
Mattia Bugatti
Michela Corsini
Paola Todeschini
Sergio Marchini
Maurizio D'Incalci
Laura Zanotti
Antonella Ravaggi
Antonella Ravaggi
Antonella Ravaggi
Fabio Facchetti
Angela Gambino
Angela Gambino
Franco Odicino
Franco Odicino
Enrico Sartori
Enrico Sartori
Alessandro Davide Santin
Stefania Mitola
Eliana Bignotti
Eliana Bignotti
Stefano Calza
Stefano Calza
author_sort Chiara Romani
collection DOAJ
description High-grade serous ovarian carcinoma (HGSOC) usually spreads directly into the peritoneal cavity following a transcoelomic dissemination route, although distant hematogenous metastasis exist and have been reported. However, no tumor markers can currently predict the risk of distant metastases in HGSOC. Claudins, belonging to tight-junction proteins, are dysregulated in HGSOC and functionally related to cancer progression. Here we analyzed claudin-3, -4, and -7 expression as potential markers of distant metastases. Using quantitative RT-PCR and immunohistochemistry we assessed the expression of claudins in primary HGSOC tissues, normal ovarian, and normal fallopian tube epithelia and correlated it with clinicopathological features, including the site of metastasis and the route of dissemination. Gene set enrichment analysis was performed on microarray-generated gene expression data to investigate key pathways in patients with distant metastases. We found the overall expression level of claudin-3, -4, and -7 mRNA decreased in HGSOC compared to normal tubal epithelium, currently considered the potential site of origin of many HGSOC. The reduced expression of claudin-7 is significantly associated with the development of distant metastases (p = 0.016), mainly by hematogenous route (p = 0.025). In patients with diminished expression of claudin-7, immunohistochemical staining revealed a heterogeneous pattern of membranous staining with discontinuous expression of claudin-7 along the cell border, indicative of a dischoesive architecture. The estimated reduction in the probability of distant disease is of 39% per unit increase in the level of claudin-7 (p = 0.03). Genes involved in epithelial to mesenchymal transition, hypoxia, and angiogenesis processes resulted strongly associated to hematogenous recurrence. Our data suggest a potential role of claudin-7 in discriminating distant metastatic events in HGSOC patients. The quantification of its expression levels could be a useful tool to identify patient deserving a personalized follow-up in terms of clinical and radiological assessment.
first_indexed 2024-12-21T04:50:47Z
format Article
id doaj.art-8a3b8f139a7a4efa94b6ab8f116c19a7
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-21T04:50:47Z
publishDate 2020-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-8a3b8f139a7a4efa94b6ab8f116c19a72022-12-21T19:15:26ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-08-011010.3389/fonc.2020.01287538185Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma PatientsChiara Romani0Chiara Romani1Valentina Zizioli2Marco Silvestri3Marco Silvestri4Laura Ardighieri5Mattia Bugatti6Michela Corsini7Paola Todeschini8Sergio Marchini9Maurizio D'Incalci10Laura Zanotti11Antonella Ravaggi12Antonella Ravaggi13Antonella Ravaggi14Fabio Facchetti15Angela Gambino16Angela Gambino17Franco Odicino18Franco Odicino19Enrico Sartori20Enrico Sartori21Alessandro Davide Santin22Stefania Mitola23Eliana Bignotti24Eliana Bignotti25Stefano Calza26Stefano Calza27Department of Molecular and Translational Medicine, University of Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, ‘Angelo Nocivelli’ Institute of Molecular Medicine, University of Brescia and ASST-Spedali Civili of Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, ItalyBiomarkers Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, ItalyUnit of Biostatistics and Bioinformatics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, ItalyDepartment of Pathology, ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Pathology, ASST Spedali Civili of Brescia, Brescia, ItalyDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, ItalyDepartment of Oncology, IRCCS, “Mario Negri” Institute for Pharmacological Research, Milan, ItalyDepartment of Oncology, IRCCS, “Mario Negri” Institute for Pharmacological Research, Milan, ItalyDivision of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, ‘Angelo Nocivelli’ Institute of Molecular Medicine, University of Brescia and ASST-Spedali Civili of Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, Department of Clinical and Experimental Sciences University of Brescia, Brescia, ItalyDepartment of Pathology, ASST Spedali Civili of Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, Department of Clinical and Experimental Sciences University of Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, Department of Clinical and Experimental Sciences University of Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, Department of Clinical and Experimental Sciences University of Brescia, Brescia, ItalyDepartment of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, United StatesDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, ‘Angelo Nocivelli’ Institute of Molecular Medicine, University of Brescia and ASST-Spedali Civili of Brescia, Brescia, ItalyDivision of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, ItalyUnit of Biostatistics and Bioinformatics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy0Big & Open Data Innovation Laboratory, University of Brescia, Brescia, ItalyHigh-grade serous ovarian carcinoma (HGSOC) usually spreads directly into the peritoneal cavity following a transcoelomic dissemination route, although distant hematogenous metastasis exist and have been reported. However, no tumor markers can currently predict the risk of distant metastases in HGSOC. Claudins, belonging to tight-junction proteins, are dysregulated in HGSOC and functionally related to cancer progression. Here we analyzed claudin-3, -4, and -7 expression as potential markers of distant metastases. Using quantitative RT-PCR and immunohistochemistry we assessed the expression of claudins in primary HGSOC tissues, normal ovarian, and normal fallopian tube epithelia and correlated it with clinicopathological features, including the site of metastasis and the route of dissemination. Gene set enrichment analysis was performed on microarray-generated gene expression data to investigate key pathways in patients with distant metastases. We found the overall expression level of claudin-3, -4, and -7 mRNA decreased in HGSOC compared to normal tubal epithelium, currently considered the potential site of origin of many HGSOC. The reduced expression of claudin-7 is significantly associated with the development of distant metastases (p = 0.016), mainly by hematogenous route (p = 0.025). In patients with diminished expression of claudin-7, immunohistochemical staining revealed a heterogeneous pattern of membranous staining with discontinuous expression of claudin-7 along the cell border, indicative of a dischoesive architecture. The estimated reduction in the probability of distant disease is of 39% per unit increase in the level of claudin-7 (p = 0.03). Genes involved in epithelial to mesenchymal transition, hypoxia, and angiogenesis processes resulted strongly associated to hematogenous recurrence. Our data suggest a potential role of claudin-7 in discriminating distant metastatic events in HGSOC patients. The quantification of its expression levels could be a useful tool to identify patient deserving a personalized follow-up in terms of clinical and radiological assessment.https://www.frontiersin.org/article/10.3389/fonc.2020.01287/fullhigh grade serous ovarian carcinomafallopian tube epitheliumclaudinsdistant metastaseshematogenous spread
spellingShingle Chiara Romani
Chiara Romani
Valentina Zizioli
Marco Silvestri
Marco Silvestri
Laura Ardighieri
Mattia Bugatti
Michela Corsini
Paola Todeschini
Sergio Marchini
Maurizio D'Incalci
Laura Zanotti
Antonella Ravaggi
Antonella Ravaggi
Antonella Ravaggi
Fabio Facchetti
Angela Gambino
Angela Gambino
Franco Odicino
Franco Odicino
Enrico Sartori
Enrico Sartori
Alessandro Davide Santin
Stefania Mitola
Eliana Bignotti
Eliana Bignotti
Stefano Calza
Stefano Calza
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients
Frontiers in Oncology
high grade serous ovarian carcinoma
fallopian tube epithelium
claudins
distant metastases
hematogenous spread
title Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients
title_full Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients
title_fullStr Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients
title_full_unstemmed Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients
title_short Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients
title_sort low expression of claudin 7 as potential predictor of distant metastases in high grade serous ovarian carcinoma patients
topic high grade serous ovarian carcinoma
fallopian tube epithelium
claudins
distant metastases
hematogenous spread
url https://www.frontiersin.org/article/10.3389/fonc.2020.01287/full
work_keys_str_mv AT chiararomani lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT chiararomani lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT valentinazizioli lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT marcosilvestri lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT marcosilvestri lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT lauraardighieri lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT mattiabugatti lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT michelacorsini lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT paolatodeschini lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT sergiomarchini lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT mauriziodincalci lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT laurazanotti lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT antonellaravaggi lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT antonellaravaggi lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT antonellaravaggi lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT fabiofacchetti lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT angelagambino lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT angelagambino lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT francoodicino lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT francoodicino lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT enricosartori lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT enricosartori lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT alessandrodavidesantin lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT stefaniamitola lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT elianabignotti lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT elianabignotti lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT stefanocalza lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients
AT stefanocalza lowexpressionofclaudin7aspotentialpredictorofdistantmetastasesinhighgradeserousovariancarcinomapatients